Business Standard

IIT Delhi, Wells Fargo sign MoU for home-based Covid-19 testing kit

The peptide-based ELISA test determines whether or not a person possesses antibodies for Covid-19 in the blood, and can help the medical fraternity fight the disease in many ways

Photo: Shutterstock
Premium

The IIT Delhi research team will be working on the peptide-based ELISA test project from its idea incubation to implementation stage. Photo: Shutterstock

Vinay Umarji Ahmedabad
The Indian Institute of Technology (IIT) Delhi and Wells Fargo have signed a memorandum of understanding (MoU) for development of a peptide-based ELISA test for the detection of Covid-19 antibodies. 

ELISA, short for serological enzyme-linked immunosorbent assay, determines whether or not a person possesses antibodies for Covid-19 in the blood. The test results can help the medical fraternity fight the disease in many ways; a significant way would be the identification of individuals with antibodies who can donate their blood as part of an experimental treatment of infected patients.

Wells Fargo International Solutions Private Limited through their philanthropic partner, United Way of

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in